Maze Therapeutics Inc
(MAZE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -96,552 | -66,465 | -32,786 | 52,231 | 81,810 |
| Depreciation Amortization | 1,904 | 1,333 | 684 | 3,297 | 2,592 |
| Accounts payable and accrued liabilities | 1,098 | 1,846 | 579 | N/A | -1,025 |
| Other Working Capital | -1,962 | -2,463 | -1,425 | -1,523 | -2,554 |
| Other Operating Activity | 11,302 | 6,181 | 3,432 | 21,949 | 17,583 |
| Operating Cash Flow | $-84,210 | $-59,568 | $-29,516 | $75,954 | $98,406 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -66,815 | N/A | N/A | N/A | N/A |
| PPE Investments | -760 | -692 | -299 | -1,147 | -542 |
| Investing Cash Flow | $-67,575 | $-692 | $-299 | $-1,147 | $-542 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 141,748 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 24,475 |
| Common Stock Issued | 2,747 | 738 | 126 | N/A | 670 |
| Other Financing Activity | 127,252 | 127,252 | 127,252 | 92,847 | -2,560 |
| Financing Cash Flow | $271,747 | $127,990 | $127,378 | $92,847 | $22,585 |
| Beginning Cash Position | 197,900 | 197,900 | 197,900 | 30,246 | 30,246 |
| End Cash Position | 317,862 | 265,630 | 295,463 | 197,900 | 150,695 |
| Net Cash Flow | $119,962 | $67,730 | $97,563 | $167,654 | $120,449 |
| Free Cash Flow | |||||
| Operating Cash Flow | -84,210 | -59,568 | -29,516 | 75,954 | 98,406 |
| Capital Expenditure | -760 | -692 | -299 | N/A | -542 |
| Free Cash Flow | -84,970 | -60,260 | -29,815 | 75,954 | 97,864 |